Journal of Virology · 2023 · 14 citations · 45 references
Life SciencesMolecular BiologyOncologyDna ReplicationGene TherapyMolecular VirologyCancer VaccinesOncogenic VirusesOncolytic Virus TherapyViral ReplicationViral VaccinesViral Vector VaccinesAdenoviral Vaccine VectorsAdenoviral VectorsAdenovirus BiologyAdenovirus VectorsHost Cell ManipulationOncolytic Viral VectorsViral Dna ReplicationViral Vectors
E1-deleted AdV vectors are considered replication deficient and are important tools for the study of virus biology, gene therapy, and large-scale vaccine development. However, deletion of the E1 genes does not completely abolish viral DNA replication in cancer cells. Here, we report, that the two E2F-binding sites in the adenoviral E2-early promoter contribute substantially to the so-called E1A-like activity in tumor cells. With this finding, on the one hand, the safety profile of viral vaccine vectors can be increased and, on the other hand, the oncolytic property for cancer therapy might be improved through targeted manipulation of the host cell.
45
Retinoblastoma protein represses transcription by recruiting a histone deacetylase
Laura Magnaghi-Jaulin, Regina Groisman, Irina Naguibneva et al. · Nature · 1998 · 910 citations